Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma

Abstract

Compared with traditional clinicopathologic models, genomic risk stratification demonstrates superior prediction of clinical outcome in STLMS and is comparable in ULMS.